BRIP1 and cancer: Given its importance in ICL repair induced by chemotherapy drugs (e.g., MMC, cisplatin), the emerging role of FANCJ to help cells deal with stalled forks suggests that the helicase may be a good target for inhibition to enhance the killing effects of drugs that perturb fork progression in rapidly dividing cancer cells.